Description:

AMC-075 Lymphoma Disease Activity and Measurement Form (L01) Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With Previously Untreated HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9F166B5D-4C13-06F1-E040-BB89AD434FAE

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9F166B5D-4C13-06F1-E040-BB89AD434FAE

Keywords:
Versions (1) ▾
  1. 10/9/17
Copyright Holder:
AIDS Malignancy Consortium
Uploaded on:

October 9, 2017

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

AMC-075 Lymphoma Disease Activity and Measurement Form (L01)

No Instruction available.

  1. StudyEvent: AMC-075 Lymphoma Disease Activity and Measurement Form (L01)
    1. No Instruction available.
Header - Lymphoma Disease Activity and Measurement Form
Reporting Period
Reporting Period
Nodal Involvement Evaluation
Is there lymph node involvement
Lymph Node Type
cm
cm
Method of Evaluation
PET scan
Extra Nodal Involvement Evaluation
Lesion completely resolved
Is measurable disease present?
Has the patient been diagnosed with a new progression?
Evaluation documented
Lesion Assessment
Comments

Similar models